Paclitaxel Injection USP 100 mg /30 mg

Bone marrow suppression (primarily neutropenia) is dose-dependent and is the dose-limiting toxicity. Neutrophil nadirs occurred at a median of 11 days. Paclitaxel Injection should not be administered to patients with baseline neutrophil counts of less than 1500 cells/mm³ ( < 1000 cells/mm³ for patients with KS). Frequent monitoring of blood counts should be instituted during Paclitaxel Injection treatment.

Call  doctor at once if patient has a serious side effect such as:

• fever, chills, body aches, flu symptoms, sores in  mouth and throat;
• pale skin, feeling light-headed or short of breath, rapid heart rate, trouble concentrating;
• easy bruising, unusual bleeding (nose, mouth, vagina, or rectum), purple or red pinpoint spots under your skin;
• flushing (warmth, redness).